Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVIALGeneric

MYOSCINT

IMCIROMAB PENTETATE

Standard Dose
N/A
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview MYOSCINT is listed in Drugs@FDA under application 103634 (BLA).

Marketing status: Discontinued Active ingredient IMCIROMAB PENTETATE Form and strength VIAL - N/A Sponsor CENTOCOR INC Submission history Latest submission status date: 1996-07-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview MYOSCINT is listed in Drugs@FDA under application 103634 (BLA). Marketing status: Discontinued Active ingredient IMCIROMAB PENTETATE Form and strength VIAL - N/A Sponsor CENTOCOR INC Submission history Latest submission status date: 1996-07-03 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.